EHVVF news CHILD-BRIGHT Network and Ehave Start Enrollment

New Post Public Reply Private Reply Replies (0) Message Board
i_like_bb_stock
95
EHVVF news CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease PR Newswire "Press Releases US - English"

OAKVILLE, Ontario , June 28, 2018 /PRNewswire/ --The CHILD- BRIGHT Network, a Canadian patient-oriented research network focussed on pediatric brain-based developmental disorders, and Ehave, Inc . (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced the start of enrollment for the CHILD- BRIGHT Mega Team research project trial, a Canadian-developed video game-based cognitive intervention that aims to improve executive functions in children with brain-based developmental disabilities such as Attention Deficit and Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), or born with a Congenital Heart Defect (CHD).

In Canada , as many as850,000children under the age of 14 are living with a brain-based developmental disability, many of whom struggle with executive functions such as self-regulation, attention, impulsivity, and academic efficiency and accuracy. CHILD- BRIGHT investigators at The Hospital for Sick Children ( SickKids ), with industry partner Ehave , have developed Mega Team, a series of innovative cognitive rehabilitation video games to improve executive functions

The clinical trial, led by Dr. Jennifer Crosbie , Associate Scientist in the SickKids Research Institute and Principal Investigator of the project within the CHILD- BRIGHT Network, will enroll 460 children between the ages of 6 and 12 with ADHD, ASD or CHD. Children will play a series of games that target response inhibition time and working memory. Via in-clinic assessments at the start and end of the trial, and again 3 months later, the research team will measure improvements in executive functions, attention and self-regulation.

"Currently, cognitive rehabilitation interventions geared to improving cognitive deficits associated with neurodevelopmental disorders place high demands on families for professional supervision, are expensive, and have minimal established impact on behavioural regulation," says Dr. Crosbie . "Our Mega Team game is innovative because it is a non-pharmacological intervention that is carried out at home, via an online gaming platform, and that requires very little trainer supervision. Because the game's platform is engaging, children are motivated to play."

Industry partner Ehave developed the mental health informatics solution Ehave Connect. The Ehave Connect platform efficiently and effectively captures data from intake to assessment to diagnosis to treatment plan to outcomes. It gives mental health clinicians and researchers a complete picture of their patients using tools they already rely upon and provides access to innovative solutions such as the CHILD- BRIGHT Mega Team game. Mega Team training is tracked on the platform, and outcomes are available to the researchers to visualize the performance over time.

"We feel there is strong clinical potential for the Mega Team game in children with ADHD, ASD and CHD," said Prateek Dwivedi , CEO of Ehave . "The trial with the CHILD- BRIGHT Network is an important step to validate the treatment impact of Mega Team with high-quality clinical rigour. It is only with this validation that clinicians, parents, and patients can feel confident in the efficacy and safety of our digital therapy as a drug-sparing or drug-reducing treatment option."

A pilot of the Mega Team project supported by the Ontario Brain Institute (OBI) and the Province of Ontario Neurodevelopmental (POND) Network was carried out in 2017 and provided initial evidence that game-based cognitive rehabilitation may be a promising intervention for executive function deficits.

CHILD- BRIGHT Mega Team enrollment information is available at www.child-bright.ca/megateam or by contacting the project coordinator at mega.team@sickkids.ca or 416-813-8210.

Project Funding Partners The CHILD- BRIGHT Mega Team project is funded by the CHILD- BRIGHT Network, under the Canadian Institutes of Health Research (CIHR) Strategy for Patient-Oriented Research (SPOR) initiative, with support from the SickKids Foundation . Early development work and pilot funding for the Mega Team project was funded by the Ontario Brain Institute (OBI), Province of Ontario Neurodevelopmental (POND) Network and in-kind support from industry partner Ehave . Dr. Crosbie is supported by the Susan Bradley Health Clinician Scientist Award in Child & Youth Mental Health and the O'Brien Scholar Program.

About the CHILD- BRIGHT Network The CHILD- BRIGHT Network, headquartered at the Research Institute of the McGill University Health Centre (RI-MUHC), is an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based developmental disabilities and their families. Using child- and family-focused approaches, we work to create novel interventions to optimize development, promote health outcomes, and deliver responsive and supportive services. Co-Directed by investigators at the BC Children's Hospital and The Hospital for Sick Children ( SickKids ), CHILD- BRIGHT is made possible thanks to a five-year grant by the Canadian Institutes of Health Research (CIHR) under Canada's Strategy for Patient-Oriented Research (SPOR), and 27 generous funding partners from public and private sectors across Canada . www.child-bright.ca

About Ehave Ehave, Inc. (OTCQB: EHVVF) is empowering the mental healthcare community with a next generation of data-rich tools designed to improve patient management, diagnosis and treatment. With Ehave Connect, Ehave's mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems ("MHS" , a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder ("ADHD" , through its collaboration with the Hospital for Sick Children (" SickKids " . Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with leading medical cannabis licensed producers. www.ehave.com



View original content:http://www.prnewswire.com/news-releases/child-bright-network-and-ehave-start-enrollment-for-cognitive-rehabilitation-trial-for-children-with-adhd-autism-and-congenital-heart-disease-300673821.html

SOURCE Ehave, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading